A Phase 2 Clinical Trial of Oxylanthanum Carbonate in Patients Receiving Maintenance Hemodialysis with Hyperphosphatemia.
Saved in:
| Title: | A Phase 2 Clinical Trial of Oxylanthanum Carbonate in Patients Receiving Maintenance Hemodialysis with Hyperphosphatemia. |
|---|---|
| Authors: | Block GA; US Renal Care, San Antonio, Texas., Chertow GM; Stanford University School of Medicine, Stanford, California., Reddy G; Unicycive Therapeutics, Inc., Los Altos, California., Hasal SJ; Unicycive Therapeutics, Inc., Los Altos, California., Mourya S; Unicycive Therapeutics, Inc., Los Altos, California., Block M; US Renal Care, San Antonio, Texas., Gupta S; Unicycive Therapeutics, Inc., Los Altos, California., Pergola PE; Renal Associates, PA, San Antonio, Texas. |
| Source: | Clinical journal of the American Society of Nephrology : CJASN [Clin J Am Soc Nephrol] 2025 Jul 14; Vol. 20 (9), pp. 1259-1267. Date of Electronic Publication: 2025 Jul 14. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wolters Kluwer Health Country of Publication: United States NLM ID: 101271570 Publication Model: Electronic Cited Medium: Internet ISSN: 1555-905X (Electronic) Linking ISSN: 15559041 NLM ISO Abbreviation: Clin J Am Soc Nephrol Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
| ISSN: | 1555-905X |
|---|---|
| DOI: | 10.2215/CJN.0000000780 |
